Accuracy of blood-based biomarkers for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice Guideline.

Keyur Patel Sumeet K Asrani Maria Isabel Fiel Deborah K LevineDaniel H LeungAndrés Duarte-Rojo Jonathan Ankin Dranoff Tarek Nayfeh Bashar Hasan Tamar Hamosh Taddei Yahya Alsawaf Samer SaadiAbdul Mounaem MajzoubApostolos ManolopoulosMuayad AlzuabiJingyi Ding Nigar SofiyevaMohammad H MuradMouaz Alsawas Don C Rockey Richard K Sterling

Published in: Hepatology (Baltimore, Md.) (2024)

Blood-based biomarkers are associated with small-to-moderate change in pretest probability for diagnosing F2-4, F3-4, and F4 in viral hepatitis, HIV-HCV coinfection, and NAFLD, with limited comparative or combination studies for other chronic liver diseases.

Keyphrases

liver fibrosis
hepatitis c virus
human immunodeficiency virus
antiretroviral therapy
hiv positive
primary care
hiv infected
sars cov
healthcare
lymph node
hiv testing
high intensity
quality improvement
men who have sex with men
south africa
case control